Ironwood Pharmaceuticals, Inc. (IRWD)
3.325
+0.12
(+3.58%)
USD |
NASDAQ |
Dec 30, 16:00
3.325
0.00 (0.00%)
After-Hours: 19:47
Ironwood Pharmaceuticals EPS Diluted (Quarterly): 0.2294 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 0.0993 |
| Plus Therapeutics, Inc. | -0.0412 |
| Pfizer Inc. | 0.6197 |
| Akebia Therapeutics, Inc. | 0.002 |
| Pyxis Oncology, Inc. | -0.3517 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 40.08M |
| Revenue (Quarterly) | 122.06M |
| Total Expenses (Quarterly) | 81.98M |
| Enterprise Value | 980.03M |
| Gross Profit Margin (Quarterly) | 99.61% |
| Profit Margin (Quarterly) | 32.84% |
| Earnings Yield | 4.65% |
| Operating Earnings Yield | 25.89% |
| Normalized Earnings Yield | 7.311 |